AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Director's Dealing Jun 1, 2018

4924_dirs_2018-06-01_783ada5a-8290-4d1d-a1dd-fe179b1478b7.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0370Q

Assura PLC

01 June 2018

1 June 2018

Assura plc

("the Company")

Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that Jayne Cottam, CFO and PDMR, has purchased 26,000 Ordinary Shares of 10 pence each in the Company ("Ordinary Shares") in accordance with the shareholding requirement section of the remuneration policy. Following the purchase, the total beneficial interest of Jayne Cottam and her connected persons in the Ordinary shares is 43,543 Ordinary Shares.

In addition, Genee Murphy, spouse of Jonathan Murphy, CEO and PDMR, transferred 72,300 Ordinary Shares into an ISA. Following the transfer, the total beneficial interest of Jonathan Murphy and his connected persons in the Ordinary Shares remains unchanged at 2,393,349 Ordinary Shares.

The Notification of Dealing Form for the PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jayne Cottam

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Share purchase for 57.5 pence per share

c)

Price(s) and volume(s)

Price(s) Volume(s)
£0.575 GBP 26,000

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price Aggregate Volume Aggregate Total
£0.575 GBP 26,000 £14,950 GBP

e)

Date of the transaction

31/05/2018

f)

Place of the transaction

XLON

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonathan Murphy

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Share transfer by Genee Murphy (spouse) to ISA for 57.4 pence per share

c)

Price(s) and volume(s)

Price(s) Volume(s)
£0.574 GBP 72,300

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price Aggregate Volume Aggregate Total
£0.574 GBP 72,300 £41,500.20 GBP

e)

Date of the transaction

31/05/2018

f)

Place of the transaction

XLON

Enquiries

Assura plc Tel: 01925 420660
Orla Ball
Edelman Tel: 0203 047 2546
John Kiely

Brett Jacobs

Rob Yates

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2018, Assura's property portfolio was valued at £1,733 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBFLFBVQFXBBV

Talk to a Data Expert

Have a question? We'll get back to you promptly.